scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YMETH.2020.06.009 |
P698 | PubMed publication ID | 32544593 |
P2093 | author name string | Huilin Li | |
Yujia Ying | |||
P2860 | cites work | The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 |
Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling | Q28076999 | ||
Ion activation methods for tandem mass spectrometry | Q28287604 | ||
Ion Activation Methods for Peptides and Proteins | Q29391863 | ||
Parsing Disease-relevant Protein Modifications from Epiphenomena: Perspective on the Structural Basis of SOD1-Mediated ALS. | Q30101060 | ||
Pepsin-Containing Membranes for Controlled Monoclonal Antibody Digestion Prior to Mass Spectrometry Analysis | Q30278544 | ||
Molecular clocks | Q30327762 | ||
Lens β-crystallins: the role of deamidation and related modifications in aging and cataract. | Q30360031 | ||
Protein hydrogen exchange measured at single-residue resolution by electron transfer dissociation mass spectrometry. | Q30378926 | ||
Recent advances in mass spectrometric analysis of protein deamidation. | Q30383499 | ||
Independent highly sensitive characterization of asparagine deamidation and aspartic acid isomerization by sheathless CZE-ESI-MS/MS. | Q30384596 | ||
Identification of Sequence Similarities among Isomerization Hotspots in Crystallin Proteins | Q30399065 | ||
Bottom up proteomics data analysis strategies to explore protein modifications and genomic variants. | Q30893312 | ||
Separation of isomeric peptides using electrospray ionization/high-resolution ion mobility spectrometry | Q33421447 | ||
Age-dependent deamidation of lifelong proteins in the human lens | Q33522366 | ||
Glutamine deamidation: differentiation of glutamic acid and gamma-glutamic acid in peptides by electron capture dissociation | Q33857391 | ||
Are ancient proteins responsible for the age-related decline in health and fitness? | Q33905239 | ||
Deamidation of human proteins | Q33947742 | ||
Isoaspartate formation and neurodegeneration in Alzheimer's disease | Q34060440 | ||
Top-down study of β2-microglobulin deamidation | Q34219743 | ||
Racemization of two proteins over our lifespan: deamidation of asparagine 76 in γS crystallin is greater in cataract than in normal lenses across the age range | Q34244542 | ||
Identification of amino acid epimerization and isomerization in crystallin proteins by tandem LC-MS | Q34300357 | ||
Age-dependent deamidation of asparagine residues in proteins | Q34348827 | ||
Molecular ageing of alpha- and Beta-synucleins: protein damage and repair mechanisms. | Q34695506 | ||
Radio-frequency-free cell for electron capture dissociation in tandem mass spectrometry | Q34732924 | ||
Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides | Q35015203 | ||
Integrated strong cation-exchange hybrid monolith coupled with capillary zone electrophoresis and simultaneous dynamic pH junction for large-volume proteomic analysis by mass spectrometry | Q35376902 | ||
Mildly acidic conditions eliminate deamidation artifact during proteolysis: digestion with endoprotease Glu-C at pH 4.5. | Q35889468 | ||
Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice | Q35913908 | ||
Characterization of deamidation of barstar using electrospray ionization quadrupole time-of-flight mass spectrometry, which stabilizes an equilibrium unfolding intermediate | Q36111510 | ||
Deamidation: Differentiation of aspartyl from isoaspartyl products in peptides by electron capture dissociation | Q36476874 | ||
Dementia-linked amyloidosis is associated with brain protein deamidation as revealed by proteomic profiling of human brain tissues | Q36596625 | ||
Biochemistry of amino acid racemization and clinical application to musculoskeletal disease | Q36626182 | ||
Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease | Q36694586 | ||
Rate of Asparagine Deamidation in a Monoclonal Antibody Correlating with Hydrogen Exchange Rate at Adjacent Downstream Residues. | Q47828405 | ||
A Comparison of Common Mass Spectrometry Approaches for Paleoproteomics | Q48134508 | ||
An integrated native mass spectrometry and top-down proteomics method that connects sequence to structure and function of macromolecular complexes | Q48186934 | ||
Top-Down Proteomics: Ready for Prime Time? | Q48262177 | ||
Characterization of Glutamine Deamidation by Long-Length Electrostatic Repulsion-Hydrophilic Interaction Chromatography-Tandem Mass Spectrometry (LERLIC-MS/MS) in Shotgun Proteomics | Q48448529 | ||
Exploring Biological and Geological Age-related Changes through Variations in Intra- and Intertooth Proteomes of Ancient Dentine | Q50093080 | ||
A High-Throughput Bioluminescent Assay to Monitor the Deamidation of Asparagine and Isomerization of Aspartate Residues in Therapeutic Proteins and Antibodies. | Q50860057 | ||
Charge variants characterization of a monoclonal antibody by ion exchange chromatography coupled on-line to native mass spectrometry: Case study after a long-term storage at +5°C. | Q50869919 | ||
Identification of multiple sources of the acidic charge variants in an IgG1 monoclonal antibody. | Q50903364 | ||
Distinguishing d- and l-aspartic and isoaspartic acids in amyloid β peptides with ultrahigh resolution ion mobility spectrometry. | Q50920962 | ||
A structural and functional study of Gln147 deamidation in αA-crystallin, a site of modification in human cataract. | Q50990718 | ||
Exploiting charge differences for the analysis of challenging post-translational modifications by capillary electrophoresis-mass spectrometry. | Q51145652 | ||
One-shot LC-MS/MS analysis of post-translational modifications including oxidation and deamidation of rat lens α- and β-crystallins induced by γ-irradiation. | Q51531170 | ||
Quantification of in vivo site-specific Asp isomerization and Asn deamidation of mAbs in animal serum using IP-LC-MS. | Q51651469 | ||
Structure of amyloid-β (20-34) with Alzheimer's-associated isomerization at Asp23 reveals a distinct protofilament interface | Q92214816 | ||
Degenerative protein modifications in the aging vasculature and central nervous system: A problem shared is not always halved | Q92217679 | ||
Negative charge at aspartate 151 is important for human lens αA-crystallin stability and chaperone function | Q92229700 | ||
An Automated and Qualified Platform Method for Site-Specific Succinimide and Deamidation Quantitation Using Low-pH Peptide Mapping | Q92369542 | ||
A Cyclic Ion Mobility-Mass Spectrometry System | Q92374949 | ||
Using bispecific antibodies in forced degradation studies to analyze the structure-function relationships of symmetrically and asymmetrically modified antibodies | Q92509360 | ||
Analysis of four therapeutic monoclonal antibodies by online capillary isoelectric focusing directly coupled to quadrupole time-of-flight mass spectrometry | Q92588504 | ||
A single Asp isomer substitution in an αA-crystallin-derived peptide induces a large change in peptide properties | Q92600219 | ||
Ionisation bias undermines the use of matrix-assisted laser desorption/ionisation for estimating peptide deamidation: Synthetic peptide studies demonstrate electrospray ionisation gives more reliable response ratios | Q92600654 | ||
A next generation setup for pre-fractionation of non-denatured proteins reveals diverse albumin proteoforms each carrying several post-translational modifications | Q92603131 | ||
Deamidation Can Compromise Antibody Colloidal Stability and Enhance Aggregation in a pH-Dependent Manner | Q92648356 | ||
Characterization of IgG1 Fc Deamidation at Asparagine 325 and Its Impact on Antibody-dependent Cell-mediated Cytotoxicity and FcγRIIIa Binding | Q92669076 | ||
All Ion Differential Analysis Refines the Detection of Terminal and Internal Diagnostic Fragment Ions for the Characterization of Biologics Product-Related Variants and Impurities by Middle-down Mass Spectrometry | Q92678589 | ||
Engineering an anti-CD52 antibody for enhanced deamidation stability | Q92745836 | ||
Streamlining the polishing step development process via physicochemical characterization of monoclonal antibody aggregates | Q92894153 | ||
Top-Down Characterization of Denatured Proteins and Native Protein Complexes Using Electron Capture Dissociation Implemented within a Modified Ion Mobility-Mass Spectrometer | Q93057441 | ||
Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments | Q93089051 | ||
Spontaneous Isomerization of Long-Lived Proteins Provides a Molecular Mechanism for the Lysosomal Failure Observed in Alzheimer's Disease | Q93089168 | ||
Protein interactome of the deamidase phosphoribosylformylglycinamidine synthetase (PFAS) by LC-MS/MS | Q93108356 | ||
Altered Protein Dynamics and Increased Aggregation of Human γS-Crystallin Due to Cataract-Associated Deamidations | Q93142025 | ||
Heterogeneity assessment of antibody-derived therapeutics at the intact and middle-up level by low-flow sheathless capillary electrophoresis-mass spectrometry | Q93157652 | ||
Analysis of Glutamine Deamidation: Products, Pathways, and Kinetics | Q93195266 | ||
A Middle-Up Approach with Online Capillary Isoelectric Focusing/Mass Spectrometry for In-Depth Characterization of Cetuximab Charge Heterogeneity | Q93207167 | ||
Does deamidation of islet amyloid polypeptide accelerate amyloid fibril formation? | Q93357051 | ||
Age-related changes in human crystallins determined from comparative analysis of post-translational modifications in young and aged lens: does deamidation contribute to crystallin insolubility? | Q36876664 | ||
Comparison of originator and biosimilar therapeutic monoclonal antibodies using comprehensive two-dimensional liquid chromatography coupled with time-of-flight mass spectrometry | Q37327298 | ||
Developability studies before initiation of process development: improving manufacturability of monoclonal antibodies | Q37364361 | ||
Site-specific characterization of (D)-amino acid containing peptide epimers by ion mobility spectrometry | Q37724249 | ||
Differentiation of isomeric amino acid residues in proteins and peptides using mass spectrometry. | Q37982946 | ||
Hydrogen deuterium mass spectrometry in drug discovery | Q38550273 | ||
Isomerization of aspartyl residues in crystallins and its influence upon cataract | Q38566934 | ||
Two-dimensional capillary zone electrophoresis-mass spectrometry for the characterization of intact monoclonal antibody charge variants, including deamidation products | Q38628030 | ||
Chromatographic, Electrophoretic, and Mass Spectrometric Methods for the Analytical Characterization of Protein Biopharmaceuticals | Q38656541 | ||
Mass Spectrometry Applied to Bottom-Up Proteomics: Entering the High-Throughput Era for Hypothesis Testing | Q38799342 | ||
Unbiased in-depth characterization of CEX fractions from a stressed monoclonal antibody by mass spectrometry | Q38852892 | ||
Rapid assessment of oxidation via middle-down LCMS correlates with methionine side-chain solvent-accessible surface area for 121 clinical stage monoclonal antibodies | Q38915146 | ||
Hydrogen deuterium exchange mass spectrometry in biopharmaceutical discovery and development - A review. | Q38962917 | ||
Glutamine deamidation: an indicator of antiquity, or preservational quality? | Q40187189 | ||
Deamidation of Human γS-Crystallin Increases Attractive Protein Interactions: Implications for Cataract | Q40754367 | ||
Differences in solution dynamics between lens β-crystallin homodimers and heterodimers probed by hydrogen-deuterium exchange and deamidation | Q40767353 | ||
Fast Comparative Structural Characterization of Intact Therapeutic Antibodies Using Hydrogen-Deuterium Exchange and Electron Transfer Dissociation | Q40994262 | ||
Quantitative proteomic study of Aspergillus Fumigatus secretome revealed deamidation of secretory enzymes. | Q41337965 | ||
The Separation and Quantitation of Peptides with and without Oxidation of Methionine and Deamidation of Asparagine Using Hydrophilic Interaction Liquid Chromatography with Mass Spectrometry (HILIC-MS). | Q41692568 | ||
Rapid survey of four Asp isomers in disease-related proteins by LC-MS combined with commercial enzymes | Q41723378 | ||
Analysis of isoaspartic Acid by selective proteolysis with Asp-N and electron transfer dissociation mass spectrometry | Q41970463 | ||
Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion | Q42081044 | ||
In-Source Decay Characterization of Isoaspartate and β-Peptides | Q42225476 | ||
Deamidation of alpha-synuclein | Q42635838 | ||
Proteins and their modifications in a medieval mummy | Q42676562 | ||
Enhanced separation and characterization of deamidated peptides with RP-ERLIC-based multidimensional chromatography coupled with tandem mass spectrometry | Q43964541 | ||
Amide molecular clocks in drosophila proteins: potential regulators of aging and other processes | Q44828835 | ||
Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides | Q44893900 | ||
High Resolution CZE-MS Quantitative Characterization of Intact Biopharmaceutical Proteins: Proteoforms of Interferon-β1. | Q45291742 | ||
Integrated Bottom-Up and Top-Down Liquid Chromatography-Mass Spectrometry for Characterization of Recombinant Human Growth Hormone Degradation Products | Q45305252 | ||
Sequence and Solution Effects on the Prevalence of d-Isomers Produced by Deamidation. | Q45969140 | ||
Automated Affinity Capture and On-Tip Digestion to Accurately Quantitate in Vivo Deamidation of Therapeutic Antibodies. | Q46155984 | ||
Deamidation of asparagine residues: direct hydrolysis versus succinimide-mediated deamidation mechanisms. | Q46157873 | ||
Method to differentiate asn deamidation that occurred prior to and during sample preparation of a monoclonal antibody | Q46203892 | ||
Fast and Effective Ion Mobility-Mass Spectrometry Separation of d-Amino-Acid-Containing Peptides | Q46293786 | ||
Capillary electrophoresis-tandem mass spectrometry as a highly selective tool for the compositional and site-specific assessment of multiple peptide-deamidation. | Q46332180 | ||
Minimizing Laboratory-Induced Decay in Bone Proteomics. | Q46424106 | ||
Characterization of charge variants of a monoclonal antibody using weak anion exchange chromatography at subunit levels | Q46440116 | ||
Chemical modifications of amyloid-β(1-42) have a significant impact on the repertoire of brain amyloid-β(1-42) binding proteins. | Q46518156 | ||
LC-MS/MS-Based Monitoring of In Vivo Protein Biotransformation: Quantitative Determination of Trastuzumab and Its Deamidation Products in Human Plasma | Q46617526 | ||
Characterization of intact protein conjugates and biopharmaceuticals using ion-exchange chromatography with online detection by native electrospray ionization mass spectrometry and top-down tandem mass spectrometry | Q46671177 | ||
Differentiation of aspartic and isoaspartic acids using electron transfer dissociation | Q46843070 | ||
Paenidase, a novel D-aspartyl endopeptidase from Paenibacillus sp. B38: purification and substrate specificity | Q46923280 | ||
Detecting deamidation products in proteins by electron capture dissociation | Q46944243 | ||
Discriminating D-amino acid-containing peptide epimers by radical-directed dissociation mass spectrometry | Q46964322 | ||
Identification of ᴅ-amino acid-containing peptides in human serum | Q47106292 | ||
The Role of Electron Transfer Dissociation in Modern Proteomics | Q47111216 | ||
Top-down characterization of endogenous protein complexes with native proteomics | Q47409854 | ||
Studies on the Proteome of Human Hair - Identification of Histones and Deamidated Keratins. | Q47700311 | ||
A Fluorescence-Based High-Throughput Coupled Enzymatic Assay for Quantitation of Isoaspartate in Proteins and Peptides. | Q51682998 | ||
Characterization of Recombinant Monoclonal Antibody Charge Variants Using OFFGEL Fractionation, Weak Anion Exchange Chromatography, and Mass Spectrometry. | Q51743053 | ||
Deamidation of N76 in human γS-crystallin promotes dimer formation. | Q53363641 | ||
Ultrasensitive Characterization of Charge Heterogeneity of Therapeutic Monoclonal Antibodies Using Strong Cation Exchange Chromatography Coupled to Native Mass Spectrometry | Q57033298 | ||
Monitoring of Deamidation and Lanthionine Formation in Recombinant Mugwort Allergen by Capillary Zone Electrophoresis (CZE)-UV and Transient Capillary Isotachophoresis-CZE-Electrospray Ionization-TOF-MS | Q57033371 | ||
Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions | Q57146442 | ||
Comprehensive characterisation of the heterogeneity of adalimumab via charge variant analysis hyphenated on-line to native high resolution Orbitrap mass spectrometry | Q57181541 | ||
Evaluation of the Effect of Trypsin Digestion Buffers on Artificial Deamidation | Q57236340 | ||
Protein deamidation in biopharmaceutical manufacture: understanding, control and impact | Q57449695 | ||
Amyloid-β containing isoaspartate 7 as potential biomarker and drug target in Alzheimer's disease | Q57721654 | ||
Intact monoclonal antibodies separation and analysis by sheathless capillary electrophoresis-mass spectrometry | Q57796941 | ||
Deamidation of Amino Acids on the Surface of Adeno-Associated Virus Capsids Leads to Charge Heterogeneity and Altered Vector Function | Q57817264 | ||
Charge variant native mass spectrometry benefits mass precision and dynamic range of monoclonal antibody intact mass analysis | Q58589011 | ||
Implications of Metal Binding and Asparagine Deamidation for Amyloid Formation | Q58765987 | ||
The use of in-strip digestion for fast proteomic analysis on tear fluid from dry eye patients | Q58802532 | ||
Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability Studies | Q59797645 | ||
Fine Endmesolithic fish caviar meal discovered by proteomics in foodcrusts from archaeological site Friesack 4 (Brandenburg, Germany) | Q60049734 | ||
The effects of demineralisation and sampling point variability on the measurement of glutamine deamidation in type I collagen extracted from bone | Q60540589 | ||
Structural and functional consequences of age-related isomerization in α-crystallins | Q64105433 | ||
Separation of β-Amyloid Tryptic Peptide Species with Isomerized and Racemized l-Aspartic Residues with Ion Mobility in Structures for Lossless Ion Manipulations. | Q64956456 | ||
Deamidation and isomerization liability analysis of 131 clinical-stage antibodies. | Q64982156 | ||
Complementary middle-down and intact monoclonal antibody proteoform characterization by capillary zone electrophoresis - mass spectrometry. | Q64985885 | ||
Deamidation of glutaminyl residues: dependence on pH, temperature, and ionic strength | Q68776856 | ||
Quantitating the relative abundance of isoaspartyl residues in deamidated proteins by electron capture dissociation | Q80334852 | ||
Novel application of electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) in shotgun proteomics: comprehensive profiling of rat kidney proteome | Q84181530 | ||
Deamidation in ricin studied by capillary zone electrophoresis- and liquid chromatography-mass spectrometry | Q86157209 | ||
Identification of Isomeric Aspartate residues in βB2-crystallin from Aged Human Lens | Q88358426 | ||
High throughput detection of deamidation using S-(5'-adenosyl)-l-homocysteine hydrolase and a fluorogenic reagent | Q88629375 | ||
Use of In Vitro Systems To Model In Vivo Degradation of Therapeutic Monoclonal Antibodies | Q88962712 | ||
Online Removal of Sodium Dodecyl Sulfate via Weak Cation Exchange in Liquid Chromatography-Mass Spectrometry Based Proteomics | Q89059232 | ||
Proteomic Analysis of Aqueous Humor from Primary Open Angle Glaucoma Patients on Drug Treatment Revealed Altered Complement Activation Cascade | Q89100912 | ||
Combination of intact, middle-up and bottom-up levels to characterize 7 therapeutic monoclonal antibodies by capillary electrophoresis - Mass spectrometry | Q89469043 | ||
Rapid online buffer exchange for screening of proteins, protein complexes and cell lysates by native mass spectrometry | Q89475588 | ||
Application of CE-MS for the analysis of histones and histone modifications | Q89515859 | ||
TUTORIAL: ION ACTIVATION IN TANDEM MASS SPECTROMETRY USING ULTRA-HIGH RESOLUTION INSTRUMENTATION | Q89645959 | ||
Characterization and quantification of succinimide using peptide mapping under low-pH conditions and hydrophobic interaction chromatography | Q90024811 | ||
Comprehensive Detection of Isopeptides between Human Tissue Transglutaminase and Gluten Peptides | Q90227760 | ||
Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens | Q90564961 | ||
Multi-Attribute Method for Quality Control of Therapeutic Proteins | Q90743535 | ||
Streamlined Characterization of an Antibody-Drug Conjugate by Two-Dimensional and Four-Dimensional Liquid Chromatography/Mass Spectrometry | Q90764550 | ||
Ion Activation Methods for Peptides and Proteins | Q91008688 | ||
Unique Impacts of Methionine Oxidation, Tryptophan Oxidation, and Asparagine Deamidation on Antibody Stability and Aggregation | Q91069919 | ||
Molecular basis for chirality-regulated Aβ self-assembly and receptor recognition revealed by ion mobility-mass spectrometry | Q91151379 | ||
A systematic approach for analysis and characterization of mispairing in bispecific antibodies with asymmetric architecture | Q91177710 | ||
Rapid Prediction of Deamidation Rates of Proteins to Assess Their Long-Term Stability Using Hydrogen Exchange-Mass Spectrometry | Q91233305 | ||
Improved Electrophoretic Separation to Assist the Monitoring of Bcl-xL Post-Translational Modifications | Q91251767 | ||
Proteomic and Unbiased Post-Translational Modification Profiling of Amyloid Plaques and Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease | Q91467860 | ||
Multiplexed Middle-Down Mass Spectrometry as a Method for Revealing Light and Heavy Chain Connectivity in a Monoclonal Antibody | Q91721835 | ||
Top-down Mass Spectrometry of Sarcomeric Protein Post-translational Modifications from Non-human Primate Skeletal Muscle | Q92133168 | ||
Isomerization of Asp7 in Beta-Amyloid Enhances Inhibition of the α7 Nicotinic Receptor and Promotes Neurotoxicity | Q92210130 | ||
P4510 | describes a project that uses | mass spectrometry | Q180809 |
P577 | publication date | 2020-06-13 | |
P1433 | published in | Methods | Q6823859 |
P1476 | title | Recent Progress in the Analysis of Protein Deamidation Using Mass Spectrometry |